ROSSARI — Rossari Biotech Income Statement

0.000.00%

Last trade - 00:00

Basic MaterialsBalancedSmall CapHigh Flyer

Annual income statement for Rossari Biotech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	14,830	16,559	18,306	20,803	23,964
Cost of Revenue
Gross Profit	3,779	4,846	5,370	6,470	7,276
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	13,427	14,958	16,479	18,931	21,896
Operating Profit	1,403	1,601	1,827	1,872	2,068
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	1,363	1,442	1,776	1,852	2,025
Provision for Income Taxes
Net Income After Taxes	977	1,073	1,307	1,364	1,492
Minority Interest
Net Income Before Extraordinary Items
Net Income	977	1,073	1,307	1,364	1,492
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	977	1,073	1,307	1,364	1,492
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	17	19.3	23.4	24.6	26.9
Dividends per Share